康缘药业：第三季度净利润5727.24万元，同比下降20.88%

Group 1 - The core viewpoint of the article indicates that Kangyuan Pharmaceutical has experienced a significant decline in both revenue and net profit for the third quarter and the first three quarters of the year [1] Group 2 - In the third quarter, the company's revenue was 701 million yuan, representing a year-on-year decrease of 17.42% [1] - The net profit for the third quarter was 57.27 million yuan, down 20.88% year-on-year [1] - For the first three quarters, the total revenue amounted to 2.343 billion yuan, reflecting a year-on-year decline of 24.59% [1] - The net profit for the first three quarters was 200 million yuan, which is a decrease of 35.63% compared to the same period last year [1]